Immunome, Inc. (NASDAQ:IMNM) Receives $27.17 Average Price Target from Analysts
Immunome, Inc. (NASDAQ:IMNM – Get Free Report) has received an average rating of “Buy” from the six research firms that are currently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1-year target price among analysts that have covered the stock in the last year […]
Immunome, Inc. (NASDAQ:IMNM – Get Free Report) has received an average rating of “Buy” from the six research firms that are currently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1-year target price among analysts that have covered the stock in the last year […]
